Sarepta Therapeutics Inc
NASDAQ:SRPT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
Hospital Mater Dei SA
BOVESPA:MATD3
|
BR |
|
Intred SpA
MIL:ITD
|
IT |
|
L
|
Li Auto Inc
NASDAQ:LI
|
CN |
|
Mermaid Maritime PCL
SGX:DU4
|
TH |
|
C
|
Cleveland-Cliffs Inc
XMUN:CVA
|
US |
|
P
|
Petrolimex Saigon Transportation and Service JSC
VN:PSC
|
VN |
|
C
|
CIT Group Inc
F:QIT1
|
US |
|
Almacenes Exito SA
NYSE:EXTO
|
CO |
Wall Street
Price Targets
SRPT Price Targets Summary
Sarepta Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SRPT
is 25.25 USD
with a low forecast of 5.05 USD and a high forecast of 94.47 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SRPT's stock price target?
Price Target
25.25
USD
According to Wall Street analysts, the average 1-year price target for
SRPT
is 25.25 USD
with a low forecast of 5.05 USD and a high forecast of 94.47 USD.
What is Sarepta Therapeutics Inc's Revenue forecast?
Projected CAGR
-12%
For the last 14 years the
compound annual growth rate for
Sarepta Therapeutics Inc's revenue is
32%.
The projected
CAGR
for the next 3 years is
-12%.
